BridgeMD
New treatment option for Multiple System Atrophy
Official title Comprehensive Swallowing Rehabilitation in Patients With MSA
ClinicalTrials.gov ID: NCT04782284
What this study is testing
- What it's testing
- The purpose of this study is to investigate the effect of comprehensive swallowing rehabilitation in patients with multiple system atrophy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Age \>19 years
- Clinically diagnosed with MSA according to the guidelines of the 2nd consensus of the Gilman criteria
- Clinically diagnosed to have dysphagia by a physiatrist
- Two or more points on the Penetration-aspiration scale (PAS) from the Videofluoroscopic swallowing study (VFSS) conducted within 3 months
You likely can't join if
- Moderate to severe cognitive dysfunction with Mini-mental State Examination score \< 19
- Comorbidities or structural abnormalities that may affect swallowing function
- Other comorbidities that make it difficult to participate in the study
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.